Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors, Summary of Recommendations
PDF | English
Image For Activity Cover
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
An easy-to-read listing of the CAP/IASLC/AMP guideline's recommendations, ordered by the strength of the recommendation.
Powered By